Analyst Ratings for Baudax Bio Inc. (BXRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/3/2023 | Noble Capital | Gregory Aurand | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
3.18 (0.19) |
-94.03% | Details |
| 5/15/2020 | JMP Securities » Updated 5/6/2021 |
Jason Butler | New Coverage | Market Outperform (N/A) |
4.00 (5.00) |
3.63 (0.19) |
-94.77% | Details |
 |
||||||||
|
||||||||
